Analyst consensus rating
Healthpeak Properties Analyst Rating: Buy
Direct answer
Healthpeak Properties's consensus rating is Buy.
19 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $22.39.
Forecast evidence checked October 27, 2026.
Get free Healthpeak Properties email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $19.02
- Average price target
- $22.39
- High price target
- $29.00
- Low price target
- $17.00
- Low target gap
- -10.6%
- Target upside
- +17.7%
- High target gap
- +52.5%
- Target range width
- 63.1%
- Consensus rating
- Buy
- Analysts
- 19
- Evidence date
- October 27, 2026
- Valid through
- November 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Healthpeak Properties?
Healthpeak Properties has a verified Buy consensus. The same dataset has an average price target of $22.39.
How far are Healthpeak Properties's low and high targets from the recorded price?
The low target implies -10.6%, while the high target implies +52.5%.
How many analysts are included in Healthpeak Properties's consensus?
The verified consensus includes 19 analysts.
How is Healthpeak Properties's target upside or downside calculated?
The average target of $22.39 is divided by the recorded price of $19.02, then one is subtracted to produce +17.7%. This does not guarantee a future return.
When was Healthpeak Properties's analyst forecast verified?
The data was verified on 2026-10-27. The dataset is valid through 2026-11-03.